MANIPAL HEALTH ENTERPRI L vs Mankind Pharma Limited
A side-by-side comparison of MANIPAL HEALTH ENTERPRI L (MANIPALHOS) and Mankind Pharma Limited (MANKIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Mankind Pharma Limited leads MANIPALHOS vs MANKIND on 13 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation04
- Profitability04
- Growth11
- Size & financial health04
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
MANKIND takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
MANKIND takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
EvenThree-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
MANKIND takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good sales growth of 20.6% CAGR over last 5 years"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend"]
- + ["Company has delivered good sales growth of 18.1% CAGR over last 5 years"]
- − ["Stock is trading at 5.95 times its book value"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.